Global Medical Head, Early Development, Interventional Oncology (INTO)

Johnson & Johnson · Spring House · $232,000–$401,350 (stated in the posting)

Apply on the company website

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at jnj.com

As guided by Our Credo, Johnson & Johnson is responsible to our employees who work with us throughout the world.  We provide an inclusive work environment where each person is considered as an individual.  At Johnson & Johnson, we respect the diversity and dignity of our employees and recognize their merit.

Job Function:

Job Sub Function:

Job Category:

All Job Posting Locations:

Job Description:

Our expertise in Innovative Medicine is informed and inspired by patients, whose insights fuel our science-based advancements. Visionaries like you work on teams that save lives by developing the medicines of tomorrow. Our Oncology team is focused on the elimination of cancer by discovering new pathways and modalities to finding treatments and cures. We lead where medicine is going and need innovators with an unwavering commitment to results. Join us in developing treatments, finding cures, and pioneering the path from lab to life while championing patients every step of the way. Learn more at https://www.jnj.com/innovative-medicine

Johnson & Johnson Innovative Medicine is currently searching for the best talent for a Global Medical Head, Early Development for Interventional Oncology in North America. This is a hybrid-based role (three days a week onsite) located in either Spring House, PA; Raritan, New Jersey; New Brunswick, New Jersey; or Cambridge, MA.

The Interventional Oncology (INTO) group, a cross-sector initiative at J&J, brings together the pharmaceutical and medical device expertise with the aim to meaningfully alter the course of cancer and improve survival. We conduct sophisticated Ph 1 - 3 clinical trials that involve the development of novel procedures and unique routes of administration for investigational cancer therapies.

The Global Medical Head in Interventional Oncology is a leader with oversight of multiple complex Early Development programs with direct responsibilities in managing staff.  The Global Medical Head provides leadership in strategizing and planning the broader development program and provides guidance and direction to clinical leaders, study responsible physicians (SRP) and the broader clinical team in executing the strategy. The Global Medical Head of Early Development, Interventional Oncology reports directly to the Vice President, Clinical Development and Scientific Affairs Head of Interventional Oncology at Johnson and Johnson Innovative Medicine

Responsibilities:

• Define the vision, strategy and accountability across the INTO Early Development Portfolio. 
• Provide expertise and support clinical leaders, SRPs and Clinical Scientists for strategy, plans for execution, product evaluation, complexity, trial cost, safety surveillance, and will be accountable for developing the strategy and plans for global regulatory submission and approval 
• Works closely with functional partners (Data Management, Biostatistics, Regulatory, Engineering, Global Development, Quality, GMS) to ensure an integrated and strategic approach to flawless execution and systematic oversight of study protocol(s) in late development in close collaboration with key functional stakeholders.
• Accountability for portfolio to remain on time and on budget through life cycle: study start-up, and directs and guides study team in study enrollment, execution, data cleaning, medical review, database lock, managing health authority responses. 
• Evaluates scientific information and new ideas to assist in identifying new research opportunities; Support the INTO Discovery Forum to advance pipeline
• Oversee with the Clinical Leader to support the development and compilation of NDA/MAAs and to support responses to Health Agency questions and HA presentations post-filing.
• May review/co-author medical publications emerging from clinical trial results.
• Acts as a liaison between the company and global Key Opinion Leaders by fostering strong relationships
• May interact with medical consultants in concert with senior clinical staff, in conducting IDMC and Investigator meetings as well as Advisory Boards.
• Proactively creates a purpose driven environment by aligning Johnson & Johnson’s Credo and Leadership Imperatives with the strategies and goals of the team and enterprise.

Qualifications:

• An MD, DO or equivalent is required. An advanced additional degree (MS or PhD) is a plus.
• A minimum of 8-10 years of experience in oncology within the pharmaceutical industry and/or academia is required.
• A trained medical Oncologist (Board certified or eligible or equivalent) is highly preferred. Consideration would be given for a non-medical oncologist with significant development experience in solid tumor oncology.
• Experience in early development oncology clinical research highly preferred
• Experience is solid tumor specifically highly preferred
• Three or more years of people management experience is required.
• A strong track record in a range of leadership roles that includes working with senior clinical staff, establishing credible relationships with external stakeholders such as opinion leaders and regulators, and demonstrating substantial experience in drug development (including experience with IND and NDA/BLA submissions) 
• Past experience in managing study start-up, directing and guiding study team in study execution, data cleaning, medical review, database lock, managing health authority responses are also needed 
• A strong commitment to oncology/hematology clinical research and the ability to work well within a matrix global team setting are required
• Knowledge of Good Clinical Practices and regulatory requirements for the conduct of high-quality oncology clinical trials is required. 
• Experience in protocol development, medical review, oversight of study conduct, running trials, data quality and safety are strongly preferred. 
• Demonstrated ability to present scientific content to diverse audiences required
• Learning agility and ability to work across multiple sectors (pharm, medical device, and or consumer) is required
• Fluent in written and spoken English with excellent communication skills is required.
• Ability to travel up to 25% of the time, both domestically and internationally.

Johnson & Johnson is an Equal Opportunity Employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, age, national origin, disability, protected veteran status or other characteristics protected by federal, state or local law. We actively seek qualified candidates who are protected veterans and individuals with disabilities as defined under VEVRAA and Section 503 of the Rehabilitation Act. 

Johnson and Johnson is committed to providing an interview process that is inclusive of our applicants’ needs. If you are an individual with a disability and would like to request an accommodation, please email the Employee Health Support Center (ra-employeehealthsup@its.jnj.com) or contact AskGS to be directed to your accommodation resource.

#LI - Hybrid

Required Skills:

Preferred Skills:

The anticipated base pay range for this position is :

Additional Description for Pay Transparency:

More jobs at Johnson & Johnson · Healthcare & Care jobs in Spring House Pennsylvania United States Of America